Positive and negative immunomodulation by opioid peptides

International Journal of Immunopharmacology

Volumn 18, Issue 1, 1996, Pages 1-16

  Roda, L Giorgio ^a   Bongiorno, Lucilla ^a   Trani, Eugenia ^a   Urbani, Alessandra ^a   Marini, Mario ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

immunomodulation; neuroimmune functions; opioid peptides

Indexed keywords

BETA ENDORPHIN; OPIATE PEPTIDE; OPIATE RECEPTOR;

CHEMOTAXIS; HUMAN; IMMUNOMODULATION; MOUSE; NATURAL KILLER CELL; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029925416     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/0192-0561(95)00105-0     Document Type: Review

References (163)

1. Ader, R. (1975). Behaviorally conditioned immunosuppression. Psychosom. Med., 37, 333-340.
2. Alvarez-Mon, A., Kehrl, J. H. & Fauci, A. S. (1985). A potential role for adrenocorticotropin in regulating human B-lymphocyte functions. J. Immun., 135, 3823-3826.
3. Aune, T. M., Kelley, K. A., Ranges, G. E. & Bombara, M. P. (1990). Serotonin-activated signal transduction via serotonin receptors on Jurkat cells. J. Immun., 145, 1826-1831.
4. Ausiello, C. M. & Roda, L. G. (1984). Leu-enkephalin binding to cultured human T-lymphocytes. Cell Biol. Int. Rep., 8, 353-362.
5. Baranic, M., Pericic, D. & Poljak-Blazi, M. (1979). The immunological reactivity of mice stressed by overcrowding and treated with haloperidol. Period. Biol., 81, 213-214.
6. Bayer, B. M., Gastonguay, M. R. & Hernandez, M. C. (1992). Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility. Immunopharmacology, 23, 117-124.
7. Bessler, H., Sztein, M. B. & Serrate, S. A. (1990). β-Endorphin modulation of IL-1-induced 1L-2 production. Immunopharmacology, 19, 5-14.
8. Bessler, H., Weizman, R., Gavish, M., Notti, I. & Djaldetti, M. (1992). Immunomodulatory effect of peripheral benzodiazepine receptor ligands on human mononuclear cells. J. Neuroimmun., 38, 19-25.
9. Bidlack, J. M., Saripalli, L. D. & Lawrence, D. M. P. (1992). κ-Opioid binding sites on a murine lymphoma cell line. Eur. J. Pharmac., 227, 257-265.
10. Bongiorno, L., Marini, M., Urbani, A., Ausiello, C.M. & Roda, L. G. (1993). Effect of stimulation on soluble proteolytic enzymes released by peripheral blood mononuclear cells. Int. J. Immunopharmac., 15, 621-629.
11. Bost, K. L. (1988). Hormone and neuropeptide receptors on mononuclear leucocytes. Prog. Allergy, 43, 68-83.
12. Bowes, M. A. & Kenny A. J. (1987). An immunohistochemical study of endopeptidase-24.11 and aminopeptidase N in lymphoid tissues. Immunology, 60, 247-253.
13. Braciale, V. L., Gavin, J. R., III & Braciale, T. J. (1982). Inducible expression of insulin receptors on T-lymphocyte clones. J. exp. Med., 156, 664-669.
14. Brady, L. S., Herkenham, M., Long, J. B. & Rothman, R. B. (1989). Chronic morphine increases μ-opiate receptor binding in rat brain: a quantitative autoradiographic study. Brain Res., 477, 382-386.
15. Briggs, J. H., McKerron, C. G., Soubami, R. L., Taylor, D. J. L. & Andrew, H. (1967). Severe systemic infections complicating "mainline" heroine addiction. Lancet, ii, 1227-1231.
16. Brodie, C. & Gelfand, E. W. (1992). Functional nerve growth factor receptors on human B-lymphocytes. J. Immun., 148, 3492-3497.
17. Brown, S. L. & Van Epps, D. E. (1986). Opioid peptides modulate production of interferon gamma by human mononuclear cells. Cell. Immun., 103, 19-26.
18. Bussiere, J. L., Adler, M. W., Rogers, T. J. & Eisenstein, T. K. (1993). Cytokine reversal of morphine-induced suppression of the antibody response. J. Pharmac. exp. Ther., 264, 591-597.
19. Cannon, W. B. (1935). Stress and strain in homeostasis. Am. J. med. Sci., 189, 1-14.
20. Cantacuzene, J. (1898). Nuvelles recherches sur le mode de destruction des vibrions dans l'organisme. Ann. Inst. Pasteur, 12, 273-300.
21. Carr, D. J. J. (1992). Neuroendocrine peptide receptors on cells of the immune system. Chem. Immun., 52, 84-105.
22. Carr, D. J. J., DeCosta, B. R., Kim, C.-H., Jacobson, A. E., Guarcello, V., Rice, K. C. & Blalock, J. E. (1989). Opioid receptors on cells of the immune system: evidence for δ and κ-classes. J. Endocrinol., 122, 161-168.
23. Carr, D. J. J., Gebhardt, B. M. & Paul, D. (1993). Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. J. Pharmac. exp. Ther., 264, 1179-1186.
24. Carr, D. J. J., Gerak, L. R. & France, C. P. (1994). Naltrexone antagonizes the analgesic and immunosuppressive effects of morphine in mice. J. Pharmac. exp. Ther., 269, 693-698.
25. Caughey, G. H., Leidig, F., Viro, N. F. & Nadel, J. A. (1988). Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J. Pharmac. exp. Ther., 244, 133-137.
26. Chang, K.-J. & Cuatrecasas, P. (1979). Multiple opioid receptors. J. biol. Chem., 254, 2610-2618.
27. Chen, Y., Mestek., A., Liu, H., Hurley, J. A. & Yu, L. (1993). Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Molec. Pharmac., 44, 8-12.
28. Cherubin, C. E. & Brown, J. (1968). Systemic infections in heroin addicts. Lancet, i, 298-299.
29. Chiappelli, F., Yamashita, N., Faisal, M., Kemeny, M., Bullington, R., Nguyen, L., Clement, L. T. & Fahey, J. L. (1991). Differential effect of beta-endorphin on three human cytotoxic cell populations. Int. J. Immunopharmac., 13, 291-297.
30. Chipkin, R. E. & Coffin, V. L. (1991). Analgesic and acute central nervous system side effects of the intravenously administered enkephalinase inhibitor SCH 32615. Pharmac. Biochem. Behav., 38, 21-27.
31. Chukwuocha, R. U., Reyes, E. & Tokuda, S. (1994). The in vivo effect of opioid peptides on the murine immune response. Int. J. Immunopharmac., 16, 205-215.
32. Clark, J. A., Lui., L., Price, M., Hersh, B., Edelson, M. & Pasternack, G. W. (1989). Kappa opiate receptor multiplicity: evidence for two U-50,488-sensitive kappa subtypes and a novel kappa subtype. J. Pharmac. exp. Ther., 251, 461-468.
33. Connelly, J. C., Skidgel, R. A., Schultz, W. W., Johnson, A. R. & Erdos, E. G. (1985). Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide. Proc. natn. Acad. Sci. U.S.A., 82, 8737-8741.
34. Costa, P., Traver, D. J., Auger, C. B. & Costa, L. G. (1994). Expression of cholinergic muscarinic receptor subtypes mRNA in rat blood mononuclear cells. Immunopharmacology, 28, 113-123.
35. Craves, F. B., Law, P. Y., Hunt, C. A. & Loh, H. H. (1978). The metabolic disposition of radiolabeled enkephalins in vitro and in situ. J. Pharmac. exp. Ther., 206, 492-506.
36. Croitoru, K., Ernst, P. B., Bienenstock, J., Padol, I. & Stanisz, M. A. (1990). Selective modulation of the natural killer activity of murine intestinal intraepithelial leucocytes by the neuropeptide substance P. Immunology, 71, 196-201.
37. Cupps, T. R. & Fauci, A. S. (1982). Corticosteroid-mediated immunoregulation in man. Immun. Rev., 65, 133-155.
38. Demetrikopoulos, M. K., Siegel, A., Schleifer, S. J., Obedi, J. & Keller, S. (1994). Electrical stimulation of the dorsal midbrain periaqueductal gray suppresses peripheral blood natural killer cell activity. Brain Behav. Immun., 8, 218-228.
39. Di Chiara, G. & North, R. A. (1992). Neurobiology of opiate abuse. Trends pharmac. Sci., 13, 185-192.
40. Drapeau, G., Chow, A. & Ward, P. E. (1991). Metabolism of bradykinin analogs by angiotensin I converting enzyme and carboxypeptidase N. Peptides, 12, 631-638.
41. 3H]methionine-enkephalin by various rat tissues in vivo and in vitro. Life Sci., 21, 907-914.
42. Evans, C. J., Keith, D. E., Jr, Morrison, H., Magendzo, K. & Edwards, R. H. (1992). Cloning of delta opioid receptor by functional expression. Science, 258, 1952-1955.
43. Ferrara, P. & Li, C. H. (1980). β-Endorphin: characteristics of binding sites in rabbit spinal cord. Proc. natn. Acad. Sci. U.S.A., 77, 5746-5748.
44. Fontana, L., Fattorossi, A., D'Amelio, R., Migliorati, A. & Perricone, R. (1987). Modulation of human concanavalin A-induced lymphocyte proliferative response by physiological concentrations of β-endorphin. Immunopharmacology, 13, 111-115.
45. Freier, D. O. & Fuchs, B. A. (1994). A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity. J. Pharmac. exp. Ther., 270, 1127-1133.
46. Friedman, E. M., Coe, C. L. & Ershler, W. B. (1994). Bidirectional effects of interleukin-1 on immune response in Rhesus monkeys. Brain Behav. Immun., 8, 87-99.
47. Gabrilovac, J. (1993). Leu-enkephalin modulates the migration inhibition of mouse splenocytes induced by cAMP-elevating agents. Int. J. Immunopharmac., 15, 557-565.
48. Gaston, L., Crombez, J.C., Lassonde, M., Bernier-Buzzanga, J. & Hodgins, S. (1991). Psychological stress and psoriasis: experimental and prospective correlation studies. Acta Derm. Venereol., 156 (Suppl.), 37-43.
49. Gavin, J. R., III (1977). Polypeptide hormones receptors on lymphoid cells. Application to the study of receptor alterations and radioreceptor assay of polypeptide hormones. In Immunopharmacology (eds Hadden, J. W., Coffey, R. G. and Spreafico, F.), pp 357-387. Plenum Publishing Co., New York.
50. Gelato, M. C. (1993). Growth hormone insulin-like growth factor I and immune function. Trends Endocrin. Metab., 4, 106-110.
51. Gilman, S. C., Schwartz, J. M., Milner, R. J., Bloom, F. E. & Feldman, J. D. (1982). β-Endorphin enhances lymphocyte proliferative responses. Proc. natn. Acad. Sci. U.S.A., 79, 4226-4230.
52. Goetzl, E. J., Adelman, D. C. & Sreedharan, S. P. (1990). Neuroimmunology. Adv. Immun., 48, 161-190.
53. 1. Peptides, 12, 995-1000.
54. Guan, L., Townsend, R., Eisenstein, T. K., Adler, M. W. & Rogers, T. J. (1994). Both T-cells and macrophages are targets of κ-opioid-induced immunosuppression. Brain Behav. Immun., 8, 229-240.
55. Guillemin, R., Vargo, T., Rossier, J., Minick, S., Ling, N., Rivier, C., Vale, W. & Bloom, F. (1977). β-endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland. Science. 197, 1360-1372.
56. Gungor, M., Gene, E., Sagduyu, H., Eroglu, I. & Koyuncuoglu, H. (1980). Effect of chronic administration of morphine on primary immune response in mice. Experientia, 36, 1309-1310.
57. Hambrook, J. M., Morgan, B. A., Rance, M. J. & Smith, C. F. (1976). Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature, 262, 782-783.
58. Hartung, H. P., Wolters, K. & Tokya, K. V. (1986). Substance P: binding properties and studies on cellular responses in guinea pig macrophages. J. Immun., 136, 3856-3863.
59. Hazum, E., Chang, K.-J. & Cuatrecasas, P. (1979). Specific nonopiate receptors for β-endorphin. Science, 205, 1033-1035.
60. Heagy, W., Laurance, M., Cohen, E. & Finberg, R. (1990). Neurohormones regulate T-cell function. J. exp. Med., 171, 1625-1633.
61. Heijnen, C. J., Bevers, C., Kavelaars, A. & Ballieux, R. E. (1986). Effect of α-endorphin on the antigen-induced primary antibody response of human blood B-cells in vitro. J. Immun., 136, 213-216.
62. + NK cells, accessory monocytes and 5-HT1A receptors. Cell. Immun., 127, 199-214.
63. Holan, V., Nakamura, S. & Minowada, J. (1992). Inhibitory versus stimulatory effects of natural human interferon-alpha on proliferation of lymphocyte subpopulations. Immunology, 75, 176-181.
64. Hosoi, J., Murphy, G. F., Egan, C. L., Lerner, E. A., Grabbe, S., Asahina, A. & Granstein, R. D. (1993). Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature, 363, 159-163.
65. Howlett, T. A. & Rees, L. H. (1986). Endogenous opioid peptides and hypothalamo-pituitary function. A. Rev. Physiol., 48, 527-536.
66. Hucklebridge, F. H., Hudspith, B. N., Lydyard, P. M. & Brostoff, J. (1990). Stimulation of human peripheral lymphocytes by methionine enkephalin and δ-selective opioid analogues, Immunopharmacology, 19, 87-91.
67. Hucklebridge, F. H., Hudspith, B. N., Muhamed, J., Lydyard, P. M. & Brostoff, J. (1989). Methionine-enkephalin stimulates in vitro proliferation of human peripheral lymphocytes via delta-opioid receptors. Brain Behav. Immun., 3, 183-189.
68. Huges, J. (1975). Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res., 88, 295-308.
69. Hussey, H. H. & Katz, S. (1950). Infections resulting from narcotic addiction: report of 102 cases. Am. J. Med., 9, 186-193.
70. Jia, L., Hara, H., Okochi, T. & Negoro, S. (1992). Regulation of β-endorphin receptor expression in mouse spleen cells with Con A and rI1-2. Int. J. Immunopharmac., 14, 809-819.
71. Johnson, H. M., Smith, E. M., Torres, B. A. & Blalock, J. E. (1982). Regulation of them vitro antibody response by neuroendocrine hormones. Proc. natn. Acad. Sci. U.S.A., 79, 4171-4174.
72. Johnson, P. S., Wang, J. B., Wang, W. F. & Uhl, G. R. (1994). Expressed mu opiate receptor couples to adenylate cyclase and phosphatidylinositol turnover. Neuroreport, 12, 507-509.
73. Joseph, D. B. & Bidlack, J. M. (1995). The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure. J. Pharmac. exp. Ther., 272, 970-976.
74. Katoh, A., Nabeshima, T., Ukai, R. & Kameyama, T. (1992). Endorphins do not affect behavioral stress responses in mice. Peptides, 13, 737-739.
75. Kavelaars, A., Ballieux, R. E. & Heijnen, C. J. (1990). Differential effects of β-endorphin on cAMP levels in human peripheral blood mononuclear cells. Brain Behav. Immun., 4, 171-179.
76. Kay, N., Allen, J. & Morley, J. E. (1984). Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity. Life Sci., 35, 53-59.
77. Kerr, M. A. & Kenny A. J. (1974). The purification and specificity of a neutral endopeptidase from rabbit kidney brush border. Biochem. J., 137, 477-488.
78. Khan, M. M., Sansoni, P., Silverman, E. D., Engelman, E. G. & Melmon, K. L. (1986). Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes. Biochem. Pharmac., 35, 1137-1142.
79. Khawaja, X. Z. & Green, I. C. (1991). Dual action of beta-endorphin on insulin release in genetically obese and lean mice. Peptides, 12, 227-233.
80. Kimball, E. S., Persico, F. J. & Vaught, J. L. (1988). Substance P, neurokinin A and neurokinin B induce generation of IL-1-like activity in P388D1 cells. J. Immun., 141, 3564-3569.
81. Koff, W. C. & Dunegan, M. A. (1985). Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. J. Immun., 135, 350-354.
82. Krug, U., Krug, F. & Cuatrecasas, P. (1972). Emergence of insulin receptors on human lymphocytes during in vitro transformation. Proc. natn. Acad. Sci. U.S.A., 69, 2604-2608.
83. Kusnecov, A. W., Husband, A. J., King, M. G. & Smith R. (1989). Modulation of mitogen-induced spleen cell proliferation and the antibody-forming cell response by beta-endorphin in vivo. Peptides, 10, 473-479.
84. Kut, J. L., Young, M. R., Crayton, J. W., Wright, M. A. & Young, M. E. (1992). Regulation of murine T-lymphocyte function by spleen cell-derived and exogenous serotonin. Immunopharmac. Immunotox., 14, 783-796.
85. Laudenslager, M. L., Ryan, S. M., Drugan, R. C., Hyson, R. L. & Maier, S. F. (1983). Coping and immunosuppression: inescapable but not escapable shock supresses lymphocyte proliferation. Science, 221, 568-570.
86. Lawrence, D. M. P. & Bidlack, J. M. (1993). The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein. J. Pharmac. exp. Ther., 266, 1678-1683.
87. + channels in alloimmune effector cell lytic function. Immunopharmac. Immunotox., 11, 165-178.
88. Lockwood, L. L., Silbert, L. H., Fleshner, M., Laudenslager, M. L., Watkins, L. R. & Maier, S. F. (1994). Morphine-induced decreases in in vivo antibody response. Brain Behav. Immun., 8, 24-36.
89. Lopker, A., Abood, L.G., Hoss, W. & Lionetti, F. J. (1980). Stereoselective muscarinic acetylcholine and opiate receptors in human phagocytic leukocytes. Biochem. Pharmac., 29, 1361-1365.
90. Lord, J. A. H., Waterfield, A. A., Hughes, J. & Kosterlitz, H. W. (1977). Endogenous opioid peptides: multiple agonists and receptors. Nature, 267, 495-499.
91. Lotz, M., Vaughan, J. H. & Carson, D. A. (1988). Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science, 241, 1218-1221.
92. Louria, D. B., Hensle, T. & Rose, J. (1967). The major medical complications of heroin addiction. Ann. intern. Med., 67, 1-22.
93. Lutz, R. & Pfister, H. (1992). Opioid receptors and their pharmacological profile. J. Receptor Res., 12, 267-286.
94. Lysle, D. T., Coussons, M. E., Watts, V. J., Bennett, E. H. & Dykstra, L. A. (1993). Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J. Pharmac. exp. Ther., 265, 1071-1078.
95. MacQueen, G. M., Marshall, J., Perdue, M., Siegel, S. & Bienenstock, J. (1989). Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science, 243, 83-85.
96. Madden, J. J., Donahoe, R. M., Zwemer-Collins, J., Shafer, D. A. & Falek, A. (1987). Binding of naloxone to human T-lymphocytes. Biochem. Pharmac., 36, 4103-4109.
97. Mandler, R. N., Biddison, W. E., Mandler, R. & Serrate, S. A. (1986). β-Endorphin augments the cytolytic activity and interferon production of natural killer cells. J. Immun., 136, 934-939.
98. Marini, M., Urbani, A., Bongiorno, L. & Roda, L. G. (1992). Hydrolysis and association of leucine enkephalin to lymphomic and erythroleukaemic cell lines, III: soluble enzymes. Int. J. Immunopharmac., 14, 995-1002.
99. Marotti, T., Rabatic, S & Gabrilovac, J. (1993). A characterization of the in vivo immunomodulation by met-enkephalin in mice. Int. J. Immunopharmac., 15, 919-926.
100. Martinez, J. L., Jr & Weinberger, S. B. (1988). Enkephalin hydrolysis in plasma is highly correlated with escape performance in the rat. Behav. Neurosci., 102, 404-408.
101. Martin-Kleiner, I. & Gabrilovac, J. (1993). Naloxone modulates NK-cell activity of human peripheral blood lymphocytes like an opioid agonist. Immunopharmac. Immunotox., 15, 179-197.
102. Mathews, P. M., Froelich, C. J., Sibbitt, W. L., Jr & Bankhurst, A. D. (1983). Enhancement of natural cytotoxicity by beta-endorphin. J. Immun., 130, 1658-1662.
103. Mazzone, A., Mazzucchelli, I., Fossati, G., Gritti, D., Fea, M. & Ricevuti, G. (1994). Granulocyte defects and opioid receptors in chronic exposure to heroin or methadone in humans. Int. J. Immunopharmac., 16, 959-967.
104. McCain, H. W., Bilotta, J. & Lamster, I. B. (1987). Endorphinergic modulation of immune function: potent action of the dipeptide glycyl-L-glutamine. Life Sci., 41, 169-176.
105. McCain, H. W., Lamster, I. B. & Bilotta, J. (1986). Immunosuppressive effects of of the opiopeptins. In Enkephalins and Endorphins (eds Plotnikoff, N. P., Faith, R. E., Murgo, A. J. and Good, R. A.). Plenum Press, New York.
106. McCain, H. W., Lamster, I. B., Bozzone, J. M. & Grbic, J. T. (1982). Beta-endorphin modulates human immune activity via non-opiate receptor mechanisms. Life Sci., 31, 1619-1624.
107. Mehrishi, J. N. & Mills, I. H. (1983). Opiate receptors on lymphocytes and platelets in man. Clin. Immun. Immunopath., 27, 240-249.
108. Nakagawara, A., Ferdais-Nabi, B. Z. & Minakami, S. (1977). An improved procedure for the diagnosis of chronic granulomatous disease, using concanavalin A and cytochalasin E. Clin. chim. Acta, 74, 173-176.
109. Nong, Y.-H., Titus, R. G., Ribeiro, J. M. C. & Remold, H. G. (1989). Peptides encoded by the calcitonin gene inhibit macrophage function. J. Immun., 143, 45-49.
110. Pacifici, R., Patrini, G., Venier, I., Parolaro, D., Zuccaro, P. & Gori, E. (1994). Effect of morphine and methadone acute treatment on immunological activity in mice: pharmacokinetic and pharmacodynamic correlates. J. Pharmac. exp. Ther., 269, 1112-1116.
111. Pasternak, G. & Woods, P. (1986). Multiple mu opiate receptors. Life Sci., 38, 1889-1898.
112. Payan, D. G. (1989). Neuropeptides and inflammation: the role of substance P. A. Rev. Med., 40, 341-352.
113. Perez-Castrillon, J.-L., Perez-Arellano, J.-L., Garcia-Palomo, J.-D., Jimenez-Lopez, A. & De Castro, S. (1992). Opioids depress in vitro human monocyte chemotaxis. Immunopharmacology, 23, 57-61.
114. Pierart, M. E., Najdovski, T., Appelboom, T. E. & Deschodt-Lanckman, M. M. (1988). Effect of human endopeptidase 24.11 ("enkephalinase"). on IL-1-induced thymocyte proliferation activity. J. Immun., 140, 3808-3811.
115. Plotnikoff, N. P. & Miller, G. C. (1983). Enkephalins as immunomodulators. Int. J. Immunopharmac., 5, 437-441.
116. Puppo, F., Corsini, G., Mangini, P., Bottaro, L. & Barreca, T. (1985). Influence of β-endorphin on phytohemagglutinin-induced lymphocyte proliferation and on the expression of mononuclear cell surface antigens in vitro. Immunopharmacology, 10, 119-125.
117. Raynor, K., Kong, H., Chen, Y., Yasuda, K., Yu, L., Bell, G. I. & Reisine, T. (1994). Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Molec. Pharmac., 45, 330-334.
118. Reisine, T. & Bell, G. I. (1993). Molecular biology of opioid receptors. Trends neurol. Sci., 16, 506-510.
119. Roscetti, G., Ausiello, C. M., Palma, C., Gulla, P. & Roda, L. G. (1988a). Enkephalin activity on antigen-induced proliferation of human peripheral blood mononucleate cells. Int. J. Immunopharmac., 10, 819-823.
120. Roscetti, G., Bongiorno, L., Urbani, A., Marini, M. & Roda, L. G. (1990). Hydrolysis and binding of leucine enkephalin to lymphomic and erythroleukaemic cell lines. Int. J. Immunopharmac., 12, 391-396.
121. Roscetti, G., Venturelli, F. & Roda, L. G. (1988b). Enkephalin-binding systems in human plasma III: comparative protection of different peptides. Neurochem. Res., 13, 221-224.
122. Rossier, J., Grensch, E. D., Rivier, C., Ling, N., Guillemin, R. & Bloom, F. E. (1977). Footshock induces stress and increases beta-endorphin levels in blood but not in brain. Nature, 270, 618-620.
123. Rovensky, J., Vigas, M., Marek, J., Blazickova, S., Korcakova, L., Vyletelkova, L. & Takac, A. (1991). Evidence for immunomodulatory properties of prolactin in selected in vitro and in vivo situations. Int. J Immunopharmac., 13, 267-272.
124. Rowland, R. R. & Tokuda, S. (1989). Dual immunomodulation by met-enkephalin. Brain Behav. Immun., 3, 171-174.
125. Rowland, R. R. R., Chukwuocha, R. & Tokuda, S. (1987). Modulation of the in vitro murine immune response by met-enkephalin. Brain Behav. Immun., 1, 342-348.
126. 3H]morphine binding to interleukin-1-activated thymocytes. J. Pharmac. exp. Ther., 263, 451-456.
127. Russell, D. H., Matrisian, L., Kibler, R., Larson, D. F., Poulos, B. & Magun, B. E. (1984a). Prolactin receptors on human lymphocytes and their modulation by cyclosporine. Biochem. biophys. Res. Commum., 121, 899-906.
128. Russell, M., Dark, K. A., Cummins, R. W., Ellman, G., Callaway, E. & Peeke, H. V. S. (1984b). Learned histamine release. Science, 225, 733-734.
129. Saksida, L. M., Galea, L. A. M. & Kavaliers, M. (1993). Antinociceptive effects of the enkephalinase inhibitor, SCH 34826, in the snail, Cepaea nemoralis. Peptides, 14, 763-765.
130. Schleifer, S. J., Keller, S. E. & Stein, M. (1984). Brain, behaviour and the immune system. Nature, 310, 456.
131. Schulte, H. M. & Allolio, B. (1990). Infusion of β-endorphin has no suppressive effect on the releasing hormone-stimulated pituitary-adrenal axis of normal human subjects. Acta Endocrinol., 123, 526-530.
132. Schulteis, G. & Martinez, J. L., Jr (1993). Experience-dependent regulation of leu-enkephalin hydrolysis in rat plasma. Peptides, 14, 161-167.
133. Schulteis, G., Rodriguez, W. A., Rodriguez, S. B. & Martinez, J. L., Jr (1993). Individual variability in Tyr-Gly-Gly formation from enkephalin hydrolysis in mouse plasma. Peptides, 14, 1083-1089.
134. 1 31 on murine splenocyte proliferation via a naloxone-resistant receptor. Biochem. biophys. Res. Commun., 3, 936-942.
135. Shahabi, N. A. & Sharp, B. M. (1993). Activation of protein kinase c rapidly down-regulates naloxone-resistant receptors for β-endorphin on U937 cells. J. Pharmac. exp. Ther., 264, 276-281.
136. Shaker, M., Shahabi, N. A. & Sharp, B. M. (1994). Expression of naloxone-resistant β-endorphin binding sites on A20 cells: effects of concanavalin A and dexamethasone. Immunopharmacology, 28, 183-192.
137. Shavit, Y., Lewis, J. W., Terman, G. W., Gale, R. P. & Liebeskind, J. C. (1984). Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science, 223, 188-190.
138. Sibinga, N. E. & Goldenstein, A. (1988). Opioid peptides and opiod receptors in cells of the immune system. A. Rev. Immun., 6, 219-249.
139. Sirinek, L. P. & O'Dorisio, M. S. (1991). Modulation of immune function by intestinal neuropeptides. Acta Oncol., 30, 509-517.
140. Sofuglu, M., Portoghese, P. & Takemori, A. (1991). Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtype. J. Pharmac. exp. Ther., 257, 676-680.
141. Strom, T. B., Lane, M. A. & George, K. (1981). The parallel, time-dependent, bimodal change in lymphocyte cholinergic binding activity and cholinergic influence upon lymphocyte-mediated cytotoxicity after lymphocyte activation. J. Immun., 127, 707-710.
142. Taylor, T., Dluhy, R. G. & Williams, G. H. (1983). β-Endorphin suppresses adrenocorticotropin and cortisol levels in normal human subjects. J. clin. Endocrinol., 57, 592-596.
143. Taub, D. D., Eisenstein, T. K., Geller, E. B., Adler, M. W. & Rogers, T. J. (1991). Immunomodulatory activity of μ- and κ-selective opioid agonists. Proc. natn. Acad. Sci. U.S.A., 88, 360-364.
144. Terenius, L. & Wahlstrom, A. (1974). Inhibitor(s) of narcotic receptor binding in brain extract and cerebrospinal fluid. Acta pharmac. tox., 35 (Suppl. 1), 55.
145. Tominaga, K., Hato, F., Kinoshita, Y., Tominaga, M. & Yamada, M. (1992). Enhancement of DNA synthesis in rat thymocytes by stimulating their muscarinic acetylcholine receptors. Cell. molec. Biol., 38, 815-822.
146. Tubaro, E., Croce, C., Cavallo, G. & Santiangeli, C. (1983). Effect of morphine on resistance to infections. J. infect. Dis., 148, 656-666.
147. Urbani, A., Bongiorno, L., Ausiello, C. M., Marini, M. & Roda, L. G. (1992). Role of hydrolysis in the association of leu-enkephalin to peripheral blood mononucleate cells. Int. J. Immunopharmac., 14, 831-839.
148. + T-cells. Cell. Immun., 154, 109-122.
149. van den Bergh, P., Rozing, J. & Nagelkerken, L. (1991a). Opioid peptides as cytokines inT-cell activation. Adv. Neuroimmun., 1, 189-203.
150. van den Bergh, P., Rozing, J. & Nagelkerken, L. (1991b). Two opposing modes of action of β-endorphin on lymphocyte function. Immunology, 72, 537-543.
151. van den Bergh, P., Rozing, J. & Nagelkerken, L. (1993). Identification of two moieties of β-endorphin with opposing effects on rat T-cell proliferation. Immunology, 79, 18-23.
152. Van Epps, D. & Saland, L. (1984). β-Endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis. J. Immun., 132, 3046-3053.
153. Venturelli, F., Roscetti, G., Possenti, R., Vita, F. & Roda, L. G. (1985). Peripheral enkephalin hydrolysis in different animal species: a comparative study. Neurochem. Res., 10, 333-342.
154. Wachsmuth, E. D. & Staber, F. G. (1977). Changes in membrane-bound aminopeptidase on bone marrow-derived macrophages during their maturation in vitro. Exp. cell Res., 109, 269-276.
155. Wang, J. B., Imai, Y., Eppler, C. M., Gregor, P., Spivak, C. E. & Uhl, G. R. (1993). μ Opiate receptor: cDNA cloning and expression. Proc. natn. Acad. Sci. U.S.A., 90, 10230-10234.
156. Weber, R. J. & Perth, A. (1989). The periaqueductal gray matter mediates opiate-induced immunosuppression. Science, 245, 188-190.
157. Wieczorek, Z., Zimecki, M., Slon, J. J. & Siemion, I. Z. (1994). The immunomodulatory activity of tetra- and tripeptides of tuftsin-kentsin group. Peptides, 15, 215-221.
158. Wiedermann, C. J., Schratzberger, P. & Kähler, C. M. (1994). Migration of neutrophils across endothelial monolayers is stimulated by treatment of the monolayers with β-endorphin. Brain Behav. Immun., 8, 270-277.
159. Wybran, J., Appelboom, T., Famaey, J.-P. & Govaerts, A. (1979). Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T-lymphocytes. J. Immun., 123, 1068-1070.
160. Yasuda, K., Raynor, K., Kong, H., Breder, C. D., Takeda, J., Reisine, T. & Bell, G. I. (1993). Cloning and functional comparison of κ and δ opioid receptors from mouse brain. Proc. natn. Acad. Sci. U.S.A., 90, 6736-6740.
161. 3H]β-endorphin in rat plasma is increased with chronic stress. Eur. J. Pharmac., 16, 229-236.
162. Young, M. R. I., Kut, J. L., Coogan, M. P., Wright, M. A., Young, M. E. & Matthews, J. (1993). Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin. Immunology, 80, 395-400.
163. Xie, G.-X, Meng, F., Mansour, A., Thompson, R. C., Hoversten, M. T., Goldstein, A., Watson, S. J. & Akil, H. (1994). Primary structure and functional expression of a guinea pig κ -opioid (dynorphin) receptor. Proc. natn. Acad. Sci. U.S.A.,91, 3779-3783.